HideChilds = False
SystemName =

Bioverativ is a global biotechnology company dedicated to transforming the lives of people living with hemophilia and other blood disorders.

Creating meaningful progress for patients

Our Purpose

At Bioverativ, a Sanofi company, we are dedicated to transforming the lives of people with haemophilia, cold agglutinin disease and other rare blood disorders. As an independent biopharmaceutical company spun out of Biogen’s haemophilia business, we bring a strong legacy of innovation, world-class science, and commitment to the rare blood disorders community. We are united by a singular purpose: to create progress where patients need it most.

We believe that great science conquers the toughest medical obstacles, and we are inspired to push scientific boundaries to make a meaningful impact in the lives of people with rare blood disorders.

Beginning with haemophilia, we will lead by doing what’s right for patients and those who care for them, and by actively working with the blood disorders community to accelerate innovation and develop life-changing treatments.  

John G. Cox, CEO

Our haemophilia therapies were the first major advancements in the treatment of haemophilia A and B in nearly two decades, and are the first extended half-life clotting factors introduced to patients. We will continue to explore the potential benefits and better understand the science of these therapies in areas of serious need, including immune tolerance induction in haemophilia patients who develop inhibitors, long-term joint health and women with bleeding disorders.

In the same spirit as in haemophilia, we will carry forward a commitment to significantly impact the lives of people with other rare blood disorders, including cold agglutinin disease, sickle cell disease and beta thalassemia.

Creating Progress, Together

Together, we are committed to making a significant, positive impact for patients and society through innovative programmes that aim to improve access to treatment, advance disease understanding, and create true partnership with the community.

Our commitment to that purpose is reflected in our name.

“Bio” refers to our legacy of scientific innovation, which we will build upon, and “ver” refers to the Latin word veritas, meaning truth. “Ativ” is based on the word active — we will actively work with the community build trust and create change for patients.